Carlyle-backed SeQuent Scientific to take full control of Turkish unit

By Joseph Rai

  • 22 Sep 2020
Premium
Credit: Reuters

SeQuent Scientific Ltd said Tuesday it has entered into a definitive agreement to acquire the 40% stake it doesn’t already own in Turkey-based veterinary products firm Provet. SeQuent will pay $17.10 million (Rs 125.5 crore) in cash to buy the stake from Provet chairman and founder Huseyin Aydin, it said in ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.